HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients

ANTONIO RIVERO ROMÁNJULIAN CARLOS DE LA TORRE CISNEROS2026-01-292026-01-29201710.1038/tpj.2016.802-s2.0-84992348023https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27531GeneticsMolecular MedicinePharmacologyHLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patientsletter